QSAM Biosciences ROCE
Quel est le ROCE de QSAM Biosciences?
Le ROCE de QSAM Biosciences, Inc. est 427.73%
Quelle est la définition de ROCE?
Le retour sur capital utilisé (ROCE) est un ratio financier qui mesure la rentabilité d'une entreprise et l'efficacité avec laquelle son capital est utilisé.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE des entreprises dans Health Care secteur sur OTC par rapport à QSAM Biosciences
Que fait QSAM Biosciences?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
Entreprises avec roce similaire à QSAM Biosciences
- PAVmed Inc a ROCE de 411.68%
- Q-Gold Resources a ROCE de 414.05%
- LiteLink Technologies a ROCE de 414.08%
- Empire Industries a ROCE de 418.52%
- 102570 a ROCE de 421.84%
- Capitan Mining a ROCE de 423.79%
- QSAM Biosciences a ROCE de 427.73%
- Mustang Bio Inc a ROCE de 433.01%
- Sonoro Gold a ROCE de 434.69%
- Nevtah Capital Management a ROCE de 448.86%
- Richland Resources International a ROCE de 448.86%
- Permian Basin Royalty Trust a ROCE de 457.43%
- Navigator Acquisition a ROCE de 463.12%